NEXT STORY
Letter of thanks from Derek Bok
RELATED STORIES
NEXT STORY
Letter of thanks from Derek Bok
RELATED STORIES
Views | Duration | ||
---|---|---|---|
31. John David | 40 | 01:06 | |
32. Working with Herb Sherman | 43 | 05:28 | |
33. The Center for the Analysis of Health Practises: Milton Weinstein | 64 | 02:47 | |
34. Important extra-departmental activities | 45 | 03:20 | |
35. Averting Armageddon | 83 | 07:04 | |
36. Going back to medical school | 51 | 02:42 | |
37. Influencing the future of public health | 53 | 01:29 | |
38. Letter of thanks from Derek Bok | 40 | 03:41 | |
39. Reasons for writing Medical Lifeboat | 53 | 02:04 | |
40. Investigating medical malpractice in New York State | 44 | 06:50 |
There is an Association of Deans of Schools of Public Health and I attended the meetings fairly regularly. There was, I think, serious question on the part of many, maybe of most, with respect to my insistence that public health was not a discipline but a, a series of problems. They were troubled to see the changes that were going on at Harvard. They expressed concern that so-called traditional public health people were not finding Harvard School a hospitable setting for them and wondered about what I was doing. I think that most schools of public health, as best I can tell, followed us with many of the changes we made and I think the general feeling on the part of deans in subsequent years, was one... was a feeling that these changes had, in general, been, been important for the future of... of public health.
Born in 1925, American Howard Hiatt set up one of the first medical oncology research and training units in the US and has headed up some of America's most prestigious medical institutions. Hiatt attended Harvard College and received his MD from the Harvard Medical School in 1948. He was a member of the team at the Pasteur Institute, Paris, that first identified and described mRNA, and he was among the first to demonstrate mRNA in mammalian cells. From 1991 to 1997, he was Secretary of the American Academy of Arts and Sciences, where he began and directs the Academy's Initiatives For Children program. He is also committed to helping disadvantaged people access decent health care.
Title: Influencing the future of public health
Listeners: Milton C. Weinstein
Milton C. Weinstein, Ph.D., is the Henry J. Kaiser Professor of Health Policy and Management at the Harvard School of Public Health and Professor of Medicine at the Harvard Medical School. At the Harvard School of Public Health he is Academic Director of the Program in Health Decision Science, and Director of the Program on Economic Evaluation of Medical Technology . He is best known for his research on cost-effectiveness of medical practices and for developing methods of economic evaluation and decision analysis in health care. He is a co-developer of the CEPAC (Cost-Effectiveness of Preventing AIDS Complications) computer simulation model, and has conducted studies on prevention and treatment of HIV infections. He is the co-developer of the Coronary Heart Disease Policy Model, which has been used to evaluate the cost-effectiveness of cardiovascular prevention and treatment. He is an author of four books: Decision Making in Health and Medicine: Integrating Evidence and Values; Cost-Effectiveness in Health and Medicine,the report of the Panel of Cost Effectiveness in Health and Medicine; Clinical Decision Analysis; and Hypertension: A Policy Perspective.He has also published more than 200 papers in peer-reviewed medical, public health, and economics journals. He is an elected member of the Institute of Medicine of the National Academy of Sciences, and a recipient of the Award for Career Achievement from the Society for Medical Decision Making. Dr. Weinstein received his A.B. and A.M. in Applied Mathematics (1970), his M.P.P. (1972), and his Ph.D. in Public Policy (1973) from Harvard University.
Tags: Harvard Medical School
Duration: 1 minute, 29 seconds
Date story recorded: September 2006
Date story went live: 24 January 2008